135 related articles for article (PubMed ID: 16275959)
1. MPs call for removal of Health Canada's breast-implant panel members.
Eggertson L
CMAJ; 2005 Nov; 173(10):1144. PubMed ID: 16275959
[No Abstract] [Full Text] [Related]
2. One-third of panel on breast implants declares conflict.
Eggertson L
CMAJ; 2005 Aug; 173(3):241. PubMed ID: 16076813
[No Abstract] [Full Text] [Related]
3. Breast implant advisory panel: more study on silicone leakage.
Eggertson L
CMAJ; 2006 Feb; 174(4):443-4. PubMed ID: 16415219
[No Abstract] [Full Text] [Related]
4. Settling for second best?
Pitts PJ
Nat Biotechnol; 2007 Jul; 25(7):715-6. PubMed ID: 17621285
[No Abstract] [Full Text] [Related]
5. Probity gone nuts.
Nat Biotechnol; 2007 May; 25(5):483. PubMed ID: 17483818
[TBL] [Abstract][Full Text] [Related]
6. Canada's approach to conflict- of-interest oversight.
Ogbogu U
CMAJ; 2007 Aug; 177(4):375-6. PubMed ID: 17698828
[No Abstract] [Full Text] [Related]
7. Conflicts of interest and the common good in alcohol policy and research.
Cook CC
Addiction; 2005 Oct; 100(10):1555-6. PubMed ID: 16185217
[No Abstract] [Full Text] [Related]
8. Science in the courtroom. A new approach.
Dresser R
Hastings Cent Rep; 1999; 29(3):26-7. PubMed ID: 10420302
[No Abstract] [Full Text] [Related]
9. Health Canada's new standards on conflict of interest.
Yeates N
CMAJ; 2007 Oct; 177(8):900; author reply 900. PubMed ID: 17923664
[No Abstract] [Full Text] [Related]
10. How experts are chosen to inform public policy: can the process be improved?
Rowe S; Alexander N; Weaver CM; Dwyer JT; Drew C; Applebaum RS; Atkinson S; Clydesdale FM; Hentges E; Higley NA; Westring ME;
Health Policy; 2013 Oct; 112(3):172-8. PubMed ID: 23415508
[TBL] [Abstract][Full Text] [Related]
11. The perverted irony of Health Canada's Special Access Programme.
Christie TK; Montaner JS
CMAJ; 2006 Jun; 174(12):1746. PubMed ID: 16754908
[No Abstract] [Full Text] [Related]
12. Canada on course to introduce permissive assisted dying regime.
Schuklenk U
J Med Ethics; 2016 Aug; 42(8):490-2. PubMed ID: 27009981
[TBL] [Abstract][Full Text] [Related]
13. Conflict questions. Advisory board members say conflicts avoidable.
Conn J
Mod Healthc; 2006 Dec; 36(48):18. PubMed ID: 17183808
[No Abstract] [Full Text] [Related]
14. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
Steinbrook R
N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
[No Abstract] [Full Text] [Related]
15. Misys' panel raises questions. Advisers could be subjected to IT conflicts of interest.
Robeznieks A
Mod Healthc; 2006 Nov; 36(44):21-2. PubMed ID: 17128948
[No Abstract] [Full Text] [Related]
16. Advisers to the nation.
Murray S
CMAJ; 2005 Oct; 173(9):1022. PubMed ID: 16247092
[No Abstract] [Full Text] [Related]
17. Corporate influence on chemical exposure levels.
Silver K
Sci People; 1989; 21(1):24-5. PubMed ID: 16408358
[No Abstract] [Full Text] [Related]
18. Office of Inspector General: CDC lax in policing advisors' conflicts of interest.
Kuehn BM
JAMA; 2010 Feb; 303(5):412. PubMed ID: 20124532
[No Abstract] [Full Text] [Related]
19. Declarations of interest by members of Health Canada's special advisory committees and panels: a descriptive study.
Lexchin J
CMAJ Open; 2019; 7(2):E334-E340. PubMed ID: 31110111
[TBL] [Abstract][Full Text] [Related]
20. Tony Clement appointed as Canada's new health minister.
Kondro W; Sibbald B
CMAJ; 2006 Mar; 174(6):754. PubMed ID: 16534074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
